Bristol-Myers To Buy Celgene; A $74 Billion Deal By: TalkMarkets January 03, 2019 at 07:31 AM EST Bristol-Myers Squibb has struck a deal to buy Celgene in a deal valued at $74 billion in equity and cash. Read More >> Related Stocks: Bristol-Myers Squibb Celgene Corp